Mirum Pharmaceuticals, Inc. (MIRM)
89.36
-3.68
(-3.96%)
USD |
NASDAQ |
Mar 05, 15:15
Mirum Pharmaceuticals Cash from Investing (Quarterly) : 1.006M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Insmed, Inc. | 389.41M |
| BridgeBio Pharma, Inc. | -13.75M |
| XOMA Royalty Corp. | 58.21M |
| CorMedix, Inc. | -291.32M |
| ADMA Biologics, Inc. | -0.276M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 6.067M |
| Cash from Financing (Quarterly) | 8.999M |
| Free Cash Flow | 54.87M |
| Free Cash Flow Per Share (Quarterly) | 0.1059 |
| Free Cash Flow to Equity (Quarterly) | 4.779M |
| Free Cash Flow to Firm (Quarterly) | 9.621M |
| Free Cash Flow Yield | 1.19% |